Search Results - "Barkham, Nick"
-
1
Real‐world evidence for subcutaneous infliximab (CT‐P13 SC) treatment in patients with ankylosing spondylitis during the coronavirus disease (COVID‐19) pandemic: A case series
Published in Clinical case reports (01-01-2022)“…The COVID‐19 pandemic emphasized the utility of subcutaneous (SC) biologics for pressured healthcare systems. The first SC form of infliximab, CT‐P13 SC,…”
Get full text
Journal Article -
2
Real‐world evidence for subcutaneous infliximab (CT‐P13 SC) treatment in patients with psoriatic arthritis during the coronavirus disease (COVID‐19) pandemic: A case series
Published in Clinical case reports (01-01-2022)“…The COVID‐19 pandemic highlighted the benefits of subcutaneous (SC) administration for healthcare systems. The first SC infliximab, CT‐P13 SC, was safe and…”
Get full text
Journal Article -
3
Statin‐induced autoimmune necrotizing myositis—A single‐center case series highlighting this potentially life‐threatening but treatable condition
Published in Clinical case reports (01-12-2020)“…Statin‐induced autoimmune necrotizing myositis is a rare but important cause muscle weakness. Withdrawal of the statin and steroid treatment alone may be…”
Get full text
Journal Article -
4
Reducing work disability in Ankylosing Spondylitis: development of a work instability scale for AS
Published in BMC musculoskeletal disorders (16-06-2009)“…The Work Instability Scale for Rheumatoid Arthritis (RA-WIS) is established and is used by physicians to identify patients at risk of job loss for rapid…”
Get full text
Journal Article -
5
The current standard of care and the unmet needs for axial spondyloarthritis
Published in Rheumatology (Oxford, England) (01-11-2018)“…Abstract The aim of this article is to explore the benefits and limitations of the established treatments for axial SpA (axSpA), including physiotherapy,…”
Get full text
Journal Article -
6
123 A case of pyrexia of unknown origin during pregnancy
Published in Rheumatology (Oxford, England) (01-04-2019)Get full text
Journal Article -
7
-
8
P015 Improving the diagnostic performance of ANCA testing: evaluating the use of a gating strategy for ANCA test requests
Published in Rheumatology (Oxford, England) (25-04-2021)“…Abstract Background/Aims Anti-neutrophil cytoplasmic antibody (ANCAs) associated vasculitis (AAV) encompasses: Granulomatosis with polyangiitis (GPA),…”
Get full text
Journal Article -
9
P181 Detection of anti-neutrophil cytoplasmic antibodies: a single-centre evaluation of the value of indirect immunofluorescence versus antigen-specific immunoassays
Published in Rheumatology (Oxford, England) (01-04-2020)“…Abstract Background Anti-neutrophil cytoplasmic antibodies (ANCAs) are valuable laboratory markers used for the diagnosis of medium and small-vessel…”
Get full text
Journal Article -
10
P075 Long COVID is associated with poor mental health in patients with rheumatic disease: results from a 14-month longitudinal study
Published in Rheumatology (Oxford, England) (23-04-2022)“…Abstract Background/Aims COVID-19 has had severe consequences across the globe and the detrimental impacts are continually emerging. Recently it has been…”
Get full text
Journal Article -
11
P198 Efficacy and safety of secukinumab in ankylosing spondylitis: real-world data from Midlands Ankylosing Spondylitis Collaboration (MASC)
Published in Rheumatology (Oxford, England) (25-04-2021)“…Abstract Background/Aims Secukinumab is an interleukin-17 inhibitor has been found to be effective in the treatment of ankylosing spondylitis (AS) in studies,…”
Get full text
Journal Article -
12
52. Not every rheumatologic headache is giant cell arteritis: a case of aseptic meningitis on a background of rheumatoid arthritis
Published in Rheumatology advances in practice (26-09-2019)“…Abstract Introduction A 65-year-old Caucasian lady had a background of longstanding seropositive rheumatoid arthritis (RA) for which multiple disease modifying…”
Get full text
Journal Article -
13
BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics
Published in Rheumatology (Oxford, England) (01-02-2017)Get full text
Journal Article -
14
Double-blind placebo-controlled trial of etanercept in the prevention of work disability in ankylosing spondylitis
Published in Annals of the rheumatic diseases (01-11-2010)“…Etanercept has been shown to be rapidly effective in suppressing disease activity in ankylosing spondylitis (AS). The aim of this study was to determine…”
Get more information
Journal Article -
15
-
16
-
17
EP38 Secukinumab provides sustained improvement of enthesitis in patients with ankylosing spondylitis: pooled analysis of four pivotal Phase 3 studies
Published in Rheumatology (Oxford, England) (01-04-2020)“…Abstract Background Enthesitis can be a debilitating extra-articular spondyloarthritis manifestation that causes considerable pain and reduced quality of life…”
Get full text
Journal Article -
18
041Knowledge of Features of Inflammatory Back Pain in Primary Care in West Midlands: A Cross-Sectional Survey
Published in Rheumatology (Oxford, England) (01-04-2016)Get full text
Journal Article -
19
Are telephone consultations here to stay in rheumatology?
Published in Rheumatology advances in practice (01-01-2021)“…Abstract Objectives During the COVID-19 pandemic, face-to-face rheumatology follow-up appointments were mostly replaced with telephone or virtual consultations…”
Get full text
Journal Article -
20